QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.107.132217v1 324/3/1028    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dudakovic, A. Articles by Hohl, R. J. Search for Related Content PubMed PubMed Citation Articles by Dudakovic, A. Articles by Hohl, R. J.

CELLULAR AND MOLECULAR

Inhibition of Geranylgeranyl Diphosphate Synthase Induces Apoptosis through Multiple Mechanisms and Displays Synergy with Inhibition of Other Isoprenoid Biosynthetic Enzymes

Department of Pharmacology (A.D., R.J.H.), Interdisciplinary Program in Molecular and Cellular Biology (A.J.W., R.J.H.), and Department of Internal Medicine (K.M.L., L.A.V., S.E.D., R.J.H.), University of Iowa, Iowa City, Iowa

Inhibitors of isoprenoid synthesis are widely used for treatment of human diseases, including hypercholesterolemia and osteoporosis, and they have the potential to be useful for treatment of cancer. Statin drugs inhibit the enzyme HMG-CoA reductase, whereas nitrogenous bisphosphonates have more recently been shown to inhibit farnesyl disphosphate synthase. In addition, our laboratory has recently developed several potent and specific bisphosphonate inhibitors of geranylgeranyl diphosphate synthase, including digeranyl bisphosphonate. Because all three enzymes fall in the same biosynthetic pathway and many of the biological effects are due to depletion of downstream products, we hypothesized that simultaneous inhibition of these enzymes would result in synergistic growth inhibition. In this study, we show that inhibition of geranylgeranyl diphosphate synthase induces apoptosis in K562 leukemia cells. This induction of apoptosis is in part dependent upon both geranylgeranyl diphosphate depletion and accumulation of farnesyl diphosphate. Combinations of either lovastatin or zoledronate with digeranyl bisphosphonate synergistically inhibited growth and induced apoptosis. These combinations also potently inhibited cellular geranylgeranylation. These results support the potential for combinations of multiple inhibitors of isoprene biosynthesis to inhibit cancer cell growth or metastasis at clinically achievable concentrations.

Address correspondence to: Dr. Raymond J. Hohl, University of Iowa, SE 313 GH, Iowa City, IA 52242. E-mail: raymond-hohl{at}uiowa.edu

This article has been cited by other articles:

				F. P. Coxon An Update on the Pharmacology of Bisphosphonates and Analogues with Lower Bone Affinity IBMS BoneKEy, October 1, 2008; 5(10): 357 - 369. [Abstract] [Full Text] [PDF]